The daily business briefing: August 25, 2016

Mylan offers discounts for EpiPens after price-hike backlash, stocks edge lower ahead of Yellen speech, and more

An EpiPen two-pack
(Image credit: Joe Raedle/Getty Images)

1. Mylan says it will help patients pay for EpiPens

Drug maker Mylan announced Thursday that it would reduce the cost to patients of its EpiPen emergency auto-injectors to treat severe allergic reactions, offering a savings card to reduce out-of-pocket costs by up to $300 for a two-pack. The move came a day after Democratic presidential nominee Hillary Clinton called for a price cut. The company has faced a mounting backlash after hiking the price for a pack of two EpiPens from $100 to as much as $700 since Mylan bought EpiPen in 2007. The company's stock plunged by 5.4 percent on Wednesday, and Mylan CEO Heather Bresch faced mounting criticism after NBC News reported her compensation had risen from $2,453,456 to $18,931,068 between 2007 and 2015.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.